Alessandro Cozzi‐Lepri

6.7k total citations
90 papers, 2.9k citations indexed

About

Alessandro Cozzi‐Lepri is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Alessandro Cozzi‐Lepri has authored 90 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Infectious Diseases, 63 papers in Virology and 23 papers in Emergency Medicine. Recurrent topics in Alessandro Cozzi‐Lepri's work include HIV Research and Treatment (63 papers), HIV/AIDS drug development and treatment (58 papers) and HIV/AIDS Research and Interventions (50 papers). Alessandro Cozzi‐Lepri is often cited by papers focused on HIV Research and Treatment (63 papers), HIV/AIDS drug development and treatment (58 papers) and HIV/AIDS Research and Interventions (50 papers). Alessandro Cozzi‐Lepri collaborates with scholars based in United Kingdom, Italy and United States. Alessandro Cozzi‐Lepri's co-authors include Antonella d’Arminio Monforte, Andrea Antinori, Andrea De Luca, Giulia Marchetti, Massimo Galli, Andrew Phillips, Antonella Castagna, Andrea Gori, Miriam Lichtner and Paola Cicconi and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Alessandro Cozzi‐Lepri

87 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Cozzi‐Lepri United Kingdom 32 2.0k 1.8k 813 742 245 90 2.9k
Massimiliano Fabbiani Italy 27 1.4k 0.7× 1.1k 0.6× 613 0.8× 602 0.8× 156 0.6× 127 2.2k
Clifford Leen United Kingdom 31 1.7k 0.8× 1.1k 0.6× 751 0.9× 1.1k 1.5× 291 1.2× 117 2.8k
Jason F. Okulicz United States 23 1.3k 0.7× 1.2k 0.6× 431 0.5× 707 1.0× 276 1.1× 137 2.2k
Kirk D. Miller United States 22 1.3k 0.6× 1.3k 0.7× 757 0.9× 491 0.7× 313 1.3× 34 2.7k
Deborah K. McMahon United States 29 3.0k 1.5× 3.0k 1.7× 810 1.0× 1.3k 1.8× 595 2.4× 85 4.5k
Kenneth Rich United States 32 1.9k 0.9× 1.2k 0.7× 881 1.1× 869 1.2× 414 1.7× 80 3.3k
Douglas Ward United States 23 2.1k 1.1× 1.7k 0.9× 1.4k 1.7× 537 0.7× 206 0.8× 44 3.0k
D. Neau France 35 1.7k 0.8× 1.2k 0.7× 845 1.0× 1.2k 1.6× 214 0.9× 152 3.2k
Joaquín Portilla Spain 23 1.4k 0.7× 940 0.5× 564 0.7× 753 1.0× 56 0.2× 160 2.3k
Camilla Tincati Italy 21 946 0.5× 1.2k 0.6× 645 0.8× 528 0.7× 516 2.1× 71 2.1k

Countries citing papers authored by Alessandro Cozzi‐Lepri

Since Specialization
Citations

This map shows the geographic impact of Alessandro Cozzi‐Lepri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Cozzi‐Lepri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Cozzi‐Lepri more than expected).

Fields of papers citing papers by Alessandro Cozzi‐Lepri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Cozzi‐Lepri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Cozzi‐Lepri. The network helps show where Alessandro Cozzi‐Lepri may publish in the future.

Co-authorship network of co-authors of Alessandro Cozzi‐Lepri

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Cozzi‐Lepri. A scholar is included among the top collaborators of Alessandro Cozzi‐Lepri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Cozzi‐Lepri. Alessandro Cozzi‐Lepri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mondi, Annalisa, Alessandro Cozzi‐Lepri, Valentina Mazzotta, et al.. (2025). Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years. International Journal of Infectious Diseases. 159. 108016–108016.
2.
Caputo, Sergio Lo, Alessandro Tavelli, Roberta Gagliardini, et al.. (2024). Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study. International Journal of Infectious Diseases. 143. 106956–106956. 2 indexed citations
3.
Saracino, Annalisa, Alessandro Cozzi‐Lepri, Milensu Shanyinde, et al.. (2018). HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients. PLoS ONE. 13(1). e0190302–e0190302. 6 indexed citations
4.
Mussini, Cristina, P Lorenzini, Alessandro Cozzi‐Lepri, et al.. (2018). Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study. BMC Medicine. 16(1). 79–79. 17 indexed citations
5.
Smit, Mikaëla, Rachel Cassidy, Alessandro Cozzi‐Lepri, et al.. (2017). Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study. PLoS ONE. 12(10). e0186638–e0186638. 91 indexed citations
6.
Rossetti, Barbara, Francesca Bai, Alessandro Tavelli, et al.. (2017). Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015. Clinical Microbiology and Infection. 24(4). 422–427. 10 indexed citations
7.
Madeddu, Giordano, Stefano Rusconi, Alessandro Cozzi‐Lepri, et al.. (2017). Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL. Infection. 45(4). 521–528. 9 indexed citations
8.
Mussini, Cristina, P Lorenzini, Massimo Puoti, et al.. (2015). Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus. PLoS ONE. 10(12). e0140877–e0140877. 10 indexed citations
9.
Lichtner, Miriam, Paola Cicconi, Serena Vita, et al.. (2014). Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients. The Journal of Infectious Diseases. 211(2). 178–186. 139 indexed citations
10.
Saira, Kazima, Xudong Lin, Jay V. DePasse, et al.. (2013). Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus. UCL Discovery (University College London). 2 indexed citations
11.
Luca, Andrea De, Katleen de Gaetano Donati, Manuela Colafigli, et al.. (2013). The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study. BMC Infectious Diseases. 13(1). 414–414. 44 indexed citations
12.
Luca, Andrea De, Milena Nasi, Simona Di Giambenedetto, et al.. (2012). Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(2). 113–120. 29 indexed citations
13.
Zoufaly, Alexander, Alessandro Cozzi‐Lepri, Ole Kirk, et al.. (2012). Immuno‐virological discordance is associated with a higher frequency of AIDS, severe non‐AIDS, and death. Journal of the International AIDS Society. 15(S4). 1–1. 2 indexed citations
14.
Cozzi‐Lepri, Alessandro & David Dunn. (2010). Long‐Term Probability of Detecting Drug‐Resistant HIV in Treatment‐Naive Patients Initiating Combination Antiretroviral Therapy. Clinical Infectious Diseases. 50(9). 1275–1285. 32 indexed citations
15.
Ammassari, Adriana, Alessandro Cozzi‐Lepri, Carlo Torti, et al.. (2007). Treatment complexity and risk of virological rebound in persons receiving cART. UCL Discovery (University College London). 2 indexed citations
16.
Cozzi‐Lepri, Alessandro, Andrea De Luca, Andrew Phillips, et al.. (2006). A Comparison between Abacavir and Efavirenz as the Third Drug Used in Combination with a Background Therapy Regimen of 2 Nucleoside Reverse‐Transcriptase Inhibitors in Patients with Initially Suppressed Viral Loads. The Journal of Infectious Diseases. 194(1). 20–28. 5 indexed citations
17.
Mussini, Cristina, Andrea Bedini, Giovanni Guaraldi, et al.. (2005). CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.. PubMed. 19(3). 287–94. 42 indexed citations
18.
Greub, Gilbert, Alessandro Cozzi‐Lepri, Bruno Ledergerber, et al.. (2002). Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy. AIDS. 16(14). 1967–1969. 95 indexed citations
19.
Perno, Carlo Federico, Francesca Ceccherini‐Silberstein, Andrea De Luca, et al.. (2002). Virologic Correlates of Adherence to Antiretroviral Medications and Therapeutic Failure. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31. S118–S122. 50 indexed citations
20.
Ammassari, Adriana, Andrea Antinori, Alessandro Cozzi‐Lepri, et al.. (2002). Relationship Between HAART Adherence and Adipose Tissue Alterations. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31. S140–S144. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026